() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Search for: "preveceutical"

PreveCeutical Signs Research and Development Agreement with UniQuest Pty Limited for Development of Caribbean Blue Scorpion Venom-Derived Natural & Synthetic Peptides

PreveCeutical Medical Inc. (“PMI”) a health and wellness company focused on utilizing nature and science for the benefit of health-conscious consumers, is pleased to announce that it signed a research and option agreement (the "Agreement") with UniQuest Pty Limited (“UniQuest”) for conducting a research program (the "Research Program") for the development of Scorpion Venom-Derived Natural & Synthetic Peptides. UniQuest is the main commercialisation company for the University of Queensland (“UQ”).
Read more

Asterion Welcomes Australian Government Awarding of Major Project Status for its Toowoomba Medicinal Cannabis Project

April 4th, 2019, Vancouver, British Columbia:  Asterion Cannabis Inc. (P.ASTR) (“Asterion”) and PreveCeutical Medical Inc. (“PreveCeutical”) (CSE: PREV, OTCQB: PRVCF, FSE: 18H), announce today that Asterion’s wholly-owned Australian subsidiary, Asterion Australia Pty Ltd, has been awarded Major Project Status for Asterion’s Toowoomba Medicinal Cannabis Project (the “Toowoomba Project” or the “Facility”) by the Australia Federal Government.
Read more

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Rolling Forward with Cannabis Production Facility

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Rolling Forward with Cannabis Production Facility June 25, 2018 Facility in Costa Mesa, California, will enable full range of cannabis distribution services Powdered cannabis CBD and THC formulations for beverage alternatives expected to drive multi-billion-dollar market Pivot Pharmaceuticals expects to have licensing to begin manufacturing by…
Read more
Get $50 in free trades.